Cargando…
Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is the seventh most common malignancy and the second most common cause of cancer-related deaths. Autophagy plays a crucial role in the development and progression of HCC. METHODS: Univariate and Lasso Cox regression analyses were performed to determine a ge...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775646/ https://www.ncbi.nlm.nih.gov/pubmed/33392087 http://dx.doi.org/10.3389/fonc.2020.591356 |
_version_ | 1783630512557916160 |
---|---|
author | Fang, Qiongxuan Chen, Hongsong |
author_facet | Fang, Qiongxuan Chen, Hongsong |
author_sort | Fang, Qiongxuan |
collection | PubMed |
description | BACKGROUND: Hepatocellular carcinoma (HCC) is the seventh most common malignancy and the second most common cause of cancer-related deaths. Autophagy plays a crucial role in the development and progression of HCC. METHODS: Univariate and Lasso Cox regression analyses were performed to determine a gene model that was optimal for overall survival (OS) prediction. Patients in the GSE14520 and GSE54236 datasets of the Cancer Genome Atlas (TCGA) were divided into the high-risk and low-risk groups according to established ATG models. Univariate and multivariate Cox regression analyses were used to identify risk factors for OS for the purpose of constructing nomograms. Calibration and receiver operating characteristic (ROC) curves were used to evaluate model performance. Real-time PCR was used to validate the effects of the presence or absence of an autophagy inhibitor on gene expression in HepG2 and Huh7 cell lines. RESULTS: OS in the high-risk group was significantly shorter than that in the low-risk group. Gene set enrichment analysis (GSEA) indicated that the association between the low-risk group and autophagy- as well as immune-related pathways was significant. ULK2, PPP3CC, and NAFTC1 may play vital roles in preventing HCC progression. Furthermore, tumor environment analysis via ESTIMATION indicated that the low-risk group was associated with high immune and stromal scores. Based on EPIC prediction, CD8+ T and B cell fractions in the TCGA and GSE54236 datasets were significantly higher in the low-risk group than those in the high-risk group. Finally, based on the results of univariate and multivariate analyses three variables were selected for nomogram development. The calibration plots showed good agreement between nomogram prediction and actual observations. Inhibition of autophagy resulted in the overexpression of genes constituting the gene model in HepG2 and Huh7 cells. CONCLUSIONS: The current study determined the role played by autophagy-related genes (ATGs) in the progression of HCC and constructed a novel nomogram that predicts OS in HCC patients, through a combined analysis of TCGA and gene expression omnibus (GEO) databases. |
format | Online Article Text |
id | pubmed-7775646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77756462021-01-02 Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma Fang, Qiongxuan Chen, Hongsong Front Oncol Oncology BACKGROUND: Hepatocellular carcinoma (HCC) is the seventh most common malignancy and the second most common cause of cancer-related deaths. Autophagy plays a crucial role in the development and progression of HCC. METHODS: Univariate and Lasso Cox regression analyses were performed to determine a gene model that was optimal for overall survival (OS) prediction. Patients in the GSE14520 and GSE54236 datasets of the Cancer Genome Atlas (TCGA) were divided into the high-risk and low-risk groups according to established ATG models. Univariate and multivariate Cox regression analyses were used to identify risk factors for OS for the purpose of constructing nomograms. Calibration and receiver operating characteristic (ROC) curves were used to evaluate model performance. Real-time PCR was used to validate the effects of the presence or absence of an autophagy inhibitor on gene expression in HepG2 and Huh7 cell lines. RESULTS: OS in the high-risk group was significantly shorter than that in the low-risk group. Gene set enrichment analysis (GSEA) indicated that the association between the low-risk group and autophagy- as well as immune-related pathways was significant. ULK2, PPP3CC, and NAFTC1 may play vital roles in preventing HCC progression. Furthermore, tumor environment analysis via ESTIMATION indicated that the low-risk group was associated with high immune and stromal scores. Based on EPIC prediction, CD8+ T and B cell fractions in the TCGA and GSE54236 datasets were significantly higher in the low-risk group than those in the high-risk group. Finally, based on the results of univariate and multivariate analyses three variables were selected for nomogram development. The calibration plots showed good agreement between nomogram prediction and actual observations. Inhibition of autophagy resulted in the overexpression of genes constituting the gene model in HepG2 and Huh7 cells. CONCLUSIONS: The current study determined the role played by autophagy-related genes (ATGs) in the progression of HCC and constructed a novel nomogram that predicts OS in HCC patients, through a combined analysis of TCGA and gene expression omnibus (GEO) databases. Frontiers Media S.A. 2020-12-18 /pmc/articles/PMC7775646/ /pubmed/33392087 http://dx.doi.org/10.3389/fonc.2020.591356 Text en Copyright © 2020 Fang and Chen http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Fang, Qiongxuan Chen, Hongsong Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma |
title | Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma |
title_full | Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma |
title_fullStr | Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma |
title_full_unstemmed | Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma |
title_short | Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma |
title_sort | development of a novel autophagy-related prognostic signature and nomogram for hepatocellular carcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775646/ https://www.ncbi.nlm.nih.gov/pubmed/33392087 http://dx.doi.org/10.3389/fonc.2020.591356 |
work_keys_str_mv | AT fangqiongxuan developmentofanovelautophagyrelatedprognosticsignatureandnomogramforhepatocellularcarcinoma AT chenhongsong developmentofanovelautophagyrelatedprognosticsignatureandnomogramforhepatocellularcarcinoma |